Loading…
Baronsmead VCT reports 7.1% NAV dip amid market volatility, highlighting resilient unquoted holdings while navigating AIM sector challenges. New investments continue.
This article covers information on Baronsmead Second Venture Trust PLC.
LON:BMDLet’s cut straight to it: Baronsmead Second Venture Trust (BSVT) just reported a 7.1% drop in net asset value (NAV) per share for the six months to March 2025. That’s not a typo, and it’s certainly not business-as-usual for this stalwart of the VCT scene. The NAV slid from 55.2p to 51.3p, before ticking up to 54.1p by end-May. What’s behind the stumble? Buckle up – we’ve got political drama, market tremors, and a classic tale of public vs private equity resilience.
First, the headline stats:
The real story? That 7.1% drop wasn’t random noise. It was a tale of two portfolios…
Chair Sarah Fromson didn’t mince words: the “period of domestic and global political uncertainty” post-November 2024 (yes, that US election) hammered sentiment. But here’s where BSVT’s hybrid structure proved its mettle:
Flat as a pancake. Zero change in value. Why? Sheer diversification. 35% of holdings gained value (notably CitySwift and Panthera Biopartners), 35% held steady, and 30% dipped (Orri and Huma Therapeutics struggled with “extending sales cycles” – govt spending sectors like health felt the pinch). This is private equity’s superpower: insulation from daily market hysterics.
Ouch. Direct AIM holdings plunged 11.6% (vs AIM index -7.1%). The WS Gresham House funds took hits too: UK Micro Cap (-3.5%), Smaller Companies (-7.5%), Multi Cap Income (-11.5%). Blame? “National insurance and minimum wage increases” squeezing UK small-caps, despite >80% of portfolio companies meeting/exceeding expectations. Brutal.
Related
Polar Capital Technology Trust sees 102% NAV growth in FY2026, beating its benchmark by 47 points thanks to AI and semiconductor exposure.
JoshuaJuly 10, 2026
Last updated
Category
InvestingViews
31 viewsLikes
No ratings yet
Occasional emails on automation, AI and finance. Unsubscribe any time.
Silver lining: Post-March, AIM holdings rebounded +4.8% in April (vs AIM +1.5%) and +5.3% in May. Volatility cuts both ways.
While markets wobbled, BSVT kept investing – strategically:
This isn’t reckless optimism. It’s the VCT playbook: deploy during downturns to capture value. As Fromson notes, this environment offers “high quality investments… at good prices.”
Exits were muted but telling:
Translation: Managers harvested gains where possible but avoided fire sales. That Cerillion return? A reminder why we stomach the volatility.
Despite the NAV dip, investor appetite held firm:
The Board’s buyback policy (capping discounts at 5%) signals confidence – and liquidity matters in choppy markets.
Fromson’s crystal ball is refreshingly candid:
Her verdict? “We remain committed to investing through the economic cycle.” Translation: Volatility isn’t an exit signal – it’s an entry point for disciplined VCTs.
BSVT’s half-year reads like a masterclass in VCT reality: NAVs wobble, small-caps suffer whiplash, but well-structured portfolios weather storms. The 7.1% dip stings, but look deeper:
This isn’t a panic signal – it’s a reminder that VCT investing rewards marathon runners, not sprinters. As the trust navigates Labour’s Autumn Budget and Trump-era trade wars, that hybrid portfolio isn’t just diversification… it’s armour.
Disclosure: This is commentary, not advice. Always dig into the full RNS before any investment decision.
Impax Q3 AUM rises to £23.3bn despite £1.7bn net outflows, driven by market gains and strong investment performance.
JoshuaJuly 10, 2026
MJ Gleeson FY2026 trading update: steady profits, mixed home sales with operational restructuring improving outlook.
JoshuaJuly 10, 2026
No comments yet - start the conversation.